Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs. Intermittent Infusion Vancomycin
NCT05823116Phase 4Completed
- Start
- May 2023
- Primary completion
- Jun 2025
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in bacterial infection. Started May 2023; status: completed.
02
Drugs
vancomycin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT05823116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05823116.